Altium Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.05M Buy
20,952
+4,480
+27% +$238K 0.08% 154
2022
Q1
$846K Buy
16,472
+4,395
+36% +$227K 0.05% 179
2021
Q4
$605K Buy
12,077
+1,426
+13% +$70.5K 0.04% 216
2021
Q3
$513K Sell
10,651
-220
-2% -$11.2K 0.04% 222
2021
Q2
$572K Buy
10,871
+2,504
+30% +$131K 0.04% 206
2021
Q1
$414K Buy
8,367
+1,903
+29% +$91.4K 0.03% 252
2020
Q4
$314K Sell
6,464
-3,253
-33% -$160K 0.03% 276
2020
Q3
$488K Buy
9,717
+796
+9% +$41K 0.05% 172
2020
Q2
$455K Buy
8,921
+3,250
+57% +$158K 0.05% 180
2020
Q1
$248K Buy
+5,671
New +$271K 0.03% 247

Other funds holding SNY

Altium Wealth Management's SNY Position: Q2 2022 in Review

Altium Wealth Management increased its Sanofi (SNY) stake by 27% in Q2 2022, buying an estimated $238K and bringing the position to 20,952 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #154.

Altium Wealth Management first reported a position in SNY in Q1 2020 and has held it in 10 quarters since. 655 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Altium Wealth Management held 20,952 shares of Sanofi worth $1.05M as of Q2 2022.
  • Altium Wealth Management bought 4,480 Sanofi shares in Q2 2022, an estimated $238K.
  • Sanofi made up 0.08% of Altium Wealth Management's portfolio in Q2 2022, its #154 holding.
  • Altium Wealth Management first reported a position in Sanofi in Q1 2020 and has held it in 10 quarters since.
  • 655 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.